Oxaliplatin Neurotoxicity and Biologics: Maximizing Clinical Benefit
Sept 14, 2010: Howard Hochster, MD
▶︎
Making a Diagnosis of PSP, CBD, or MSA
▶︎
Chemotherapy induced Neuropathy: What you need to know as a patient or provider
▶︎
Phase II Study of Seribantumab in Tumors Harboring NRG1 Fusions
▶︎
Improving Transdermal Fentanyl Prescribing
▶︎
Advanced GI Cancers: A Focus on CRC and Yale’s Role in Developing Novel Therapeutics and Biomarkers
▶︎
Engineering & Manufacture of Second Generation ADCs: Tools & Techniques - A Webinar hosted by Lonza
▶︎
How to Focus to Change Your Brain | Huberman Lab Essentials
▶︎
Updates on Progressive Supranuclear Palsy(PSP) & Corticobasal Degeneration(CBD): Tale of Two Cousins
▶︎
S2 Episode 5: Adjuvant Chemo in Colorectal Cancer: What's Working Now?
▶︎
Implementation Science Theories, Models, and Frameworks
▶︎
Together Against Melanoma: An Educational Symposium for Patients and Caregivers
▶︎
Donor Profiling and Cell Isolation for Scalable Cell and Gene Therapy Manufacturing
▶︎
Managing Toxicities of EGFR Inhibitors in Lung Cancer – Drs. Azam Farooqui & Joshua Sabari
▶︎
Partnering with Patients: Alex Taylor
▶︎
Controversy Debate 4: Treatment algorithms in metastatic CRC - NCCN guidelines
▶︎
Updates & Innovations in ALS Clinical Trial Landscape by Dr. Jinsy Andrews
▶︎
Cancer Chronicles - Treatment #2 - Folfox
▶︎
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
▶︎
New Therapies for PMR & GCA
▶︎